Multiplexed Diagnostics Market Could be Solved by Development of Automated Equipment

In a recent publication released by Transparency Market Research (TMR), a comparative study of the global multiplexed diagnostics market is presented, taking into consideration past performance, present market conditions, and future prospects of this industry.

The global multiplexed diagnostics market had reached a value of US$2.8 billion in 2012. It is likely to attain an expected value of US$9.8 billion in 2019, growing at a 19.4% CAGR from 2013 to 2019.

Get Free Sample Research Report: http://goo.gl/5RGmey

The research report offers a detailed study on the multiplexed diagnostics market that highlights the market trends prevalent in this industry and its effect on the future growth of the market. The research report is titled “Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”.

Multiplexed diagnostics is a technique that provides fast results in limited samples, thereby saving both time and money. It provides great benefits such as rapid detection and analysis of various assays in parallel, declined cost for reagents, labor, and consumables, reduced time duration by permitting one to read large volumes of data at once and enabling the testing of a host of markers at the same time, and assurance of accurate test results through the addition of quality standards, internal quality controls, and calibration curves. Saving precious samples and increasing sample output are the added advantages of multiplexed diagnostics technique.

Based on the types of technology, the medium density multiplexed assay segment is leading the entire multiplexed diagnostics market at present. Low density multiplexed diagnostics assays follows suit. Antibody arrays and bead-based arrays are the most utilized multiplexed diagnostics techniques. The reason behind the dominance of medium density arrays is their multiple applications in other technologies used in multiplexed diagnostics.

Based on geographical distribution, North America dominates the multiplexed diagnostics market across the globe. Advanced medical and healthcare infrastructure, developed technology, and increasing pace of adoption are some of the key factors that are pushing the multiplexed diagnostics market ahead in this region. Asia Pacific is an attractive market for multiplexed diagnostics because of the rapid growth in medical and healthcare industry in this region. Furthermore, Asia Pacific is home to more than 50% of the global population and exhibits the highest prevalence of cardiac ailments and infectious diseases. Japan holds the dominant market stature at present and is followed by India and China.

Request a Brochure: : http://goo.gl/5RGmey

The report also includes company profiles of key players of within the multiplexed diagnostics market such as Seegene, Inc., Life Technologies Corporation, Luminex Corporation, Gen-Probe, Inc., Illumina, Inc., F. Hoffman-La Roche, Ltd., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., bioMerieux, Inc., and Affymetrix, Inc.

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

90 State Street, Suite 700 Albany, NY 12207

This release was published on openPR.